RCC
FDA Approves Nivolumab-Cabozantinib as First-Line Treatment of Advanced RCC
The FDA approved nivolumab in combination with cabozantinib for the first-line treatment of patients with advanced ...
FEBRUARY 10, 2021
Keytruda Gains 2 New First-Line Indications: NSCLC and RCC
The FDA approved pembrolizumab (Keytruda, Merck) for the first-line treatment of patients with stage III/IV ...
APRIL 24, 2019
Load more